Poultry Medicine/Pharmaceuticals Market

The report "Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029", poultry medicine/pharmaceuticals market is projected to reach USD 6.68 billion in 2029 from USD 5.01 billion in 2024, at a CAGR of 5.9% between 2024 and 2029.

Browse 500 market data Tables and 56 Figures spread through 424 Pages and in-depth TOC on "Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/poultry-medicine-pharmaceuticals-market-112094232.html

With the surging consumption of poultry meat and eggs around the world, particularly in the emerging economies where such products are the major source of protein, the demand for poultry medicine/pharmaceuticals is on the rise. This growth leads to an increase in the extent of poultry farming which in regard to the degree of risk of infections levels such as Newcastle disease and Coccidiosis that poultry has calls for appropriate disease management interventions. The increased concern on food safety and the reduction of antibiotic usage has prompted farms to seek alternatives such as probiotics, immune boosters and advanced vaccines for sustainable health management of the flocks. Furthermore, health care marketers are taking note of the growth of the poultry industry in most of the countries and are introducing new health care solutions in these countries aimed at improving production as well meeting regulatory requirements in the production process which has further boosted the growth of the market.

Chickens segment is expected to account for the largest share, by animal type in the poultry medicine/pharmaceuticals market during the forecast period.

The poultry medicine/pharmaceuticals market is largely determined by chickens, as demand for chicken meat and chicken eggs is rising, considering that these are readily available and inexpensive forms of protein. This increasing demand has in turn brought about the increase in poultry intensive faring especially in the developing countries, which comes with an increase in the use of medicine/pharmaceuticals to enhance the health and production of chickens. Chickens suffer from a number of diseases, including Newcastle disease and Coccidiosis, thus there is continuous need for vaccines, antibiotics and other health products such as probiotics. Moreover, more stringent biosecurity and food safety regulations are encouraging poultry producers to embrace preventive health care and advanced disease management and control techniques. Innovations in vaccines such as in ovo technologies enhance effective large scale vaccination and the volume of chicken utilization in poultry medicine/pharmaceuticals.

Vaccines segment is expected to account for the largest share, by product in the poultry medicine/pharmaceuticals market during the forecast period.

Vaccines hold the largest market share of poultry medicine/pharmaceuticals as they contribute to preventing widespread infectious diseases such as Newcastle disease, Infectious Bronchitis, and Avian Influenza that could lead to a severe loss in poultry farming. Vaccination plays an important role in healthy flocks, productivity, and biosecurity; hence it is a significant part of poultry disease management. Vaccines are among the best sustainable and effective alternatives to control diseases during outbreaks without any risk of antimicrobial resistance due to growing antibiotic use placed under increasing regulatory constraints. When it comes to vaccine delivery systems, for instance, in-egg vaccination was improved in such a way that it enabled immunization to be highly efficient and scalable enough to allow for the wide uptake of vaccines as a single mode of control method of the disease in large poultry productions. Additionally, this put vaccines in a predominant position as a product line in this market.

Newcastle disease segment is expected to account for the largest share, by product in the poultry medicine/pharmaceuticals market during the forecast period.

Newcastle disease holds the largest share of poultry medicine/pharmaceuticals market by disease indication due to its global prevalence and substantial loss it causes in poultry production. The contagious nature of this disease and its possible impact on commercial and backyard poultry flocks are an even bigger concern to the management of poultry health. Extensive vaccination programs, driven by innovations in live attenuated, inactivated, and recombinant vaccines, have been the main factors for market dominance. The increasing focus on prevention and control measures, particularly in high poultry density areas, continues to drive growth in this segment.

Oral segment is expected to account for the largest share, by route of administration in the poultry medicine/pharmaceuticals market during the forecast period.

The oral route of administration holds the largest share in the poultry medicine/pharmaceuticals market. Administration through water or feed can be easily achieved without great labor input and thus seems to be cost-effective as well as efficient. However, it does achieve the uniform distribution across the whole flock, eliminating individual labor-intensive handling of the birds. This method is popularly used for a host of products such as antibiotics, probiotics, vaccines, and nutritional supplements; therefore, it is also very versatile in its application - preventive and therapeutic. This is also supported by scalability, as oral administration applies to large-scale poultry operations and can be applied in all operations that would require maximum disease management in order to ensure health and productivity among the flock. The oral route has emerged as the dominant application in the poultry medicine/pharmaceuticals market, due to its suitability and practicality for large-scale poultry farming.

In 2023, North America accounted for the largest share of the poultry medicine/pharmaceuticals market.

The poultry medicine/pharmaceuticals market is dominated by North America as a result of advanced poultry farming systems prevalent in the region, high poultry products intake, and greater concern for biosecurity and disease control. The region is characterized by existing legislation that encourages responsible antibiotic use and as a consequence drive producers to vaccines and other health solutions in the production of food. Continuous investments in research and development as well as modern technologies put in place for the management and therapy of diseases further promotes upward movement of this market. On top of that, due to the fact that there is a growing need for sustainable as well as high-yield systems of poultry rearing, the production of medicines that assist in maintaining flocks health and productivity has increased in the region thereby further entrenching North America’s market leader position.

Key Market Players:

The key players in the global poultry medicine/pharmaceuticals market are MSD (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Zoetis Service LLC (US), Virbac (France), Phibro Animal Health (US), Hester Biosciences Limited (India), Meiji Animal Health (Japan), Venky’s India (India), Bimeda Corporate (Ireland), Calier (Spain), Hipra (Spain), Vetanco (Argentina), Vaxxinova (Netherlands), Biovac Group (Israel), Kemin Industries (US), O.L.KAR Agrozoovet Service (Ukraine), Indovax (India), Avimex (Mexico), Synthese Elevage (France), Provet Pharma Pvt Ltd (India), Huvepharma (Bulgaria), Romvac Company (Romania), and VMN Pharmaceuticals (Turkey).

Don’t miss out on business opportunities in Poultry Medicine/Pharmaceuticals Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]